AMERICAN CENTURY COMPANIES INC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Position in NRIX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$420,547

-$789,336 QoQ

Shares Held

17,335

-77.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#134

of 210 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. NRIX ranks #127 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$420,547	17,335	-77.8%	Shares	Defined	2026-08-12
2026-03-31	$1,209,883	78,057	+82.0%	Shares	Defined	2026-05-15
2025-12-31	$813,395	42,878	+64.2%	Shares	Defined	2026-02-13
2025-09-30	$241,330	26,118	+158.0%	Shares	Defined	2025-11-12
2024-06-30	$211,287	10,124	-83.1%	Shares	Defined	2024-08-07
2024-03-31	$882,970	60,066	+38.8%	Shares	Defined	2024-05-14
2023-12-31	$446,752	43,290	+40.4%	Shares	Defined	2024-02-13
2023-09-30	$242,394	30,839	+33.7%	Shares	Defined	2023-11-13
2023-06-30	$230,399	23,063	+84.0%	Shares	Defined	2023-08-14
2023-03-31	$111,284	12,532	+21.3%	Shares	Defined	2023-05-11
2022-12-31	$113,445	10,332	—	Shares	Defined	2023-02-13
No filing history on record for this holder in this stock.